Josef Penninger
Josef Martin Penninger (born September 5, 1964 in Gurten , Upper Austria ) is an Austrian geneticist and was Scientific Director at the IMBA ( Institute for Molecular Biotechnology of the Austrian Academy of Sciences ) in Vienna from 2003 to 2018 .
In 2018 he took over the management of the Life Sciences Institute at the University of British Columbia .
Life
After attending the humanistic grammar school in Ried im Innkreis , he studied medicine , art history and Spanish at the University of Innsbruck from 1982 to 1988 . In 1990 he received his doctorate with the thesis Phenotypical and functional analysis of intrathymic nurse (TCN) -Lymphocytes , which he had written with the Innsbruck geriatric researcher Georg Wick . From 1990 to 1994 he worked as a post-doctoral student at the Ontario Cancer Institute , then until 2003 at the Department of Immunology and Medical Biophysics at the University of Toronto (as Principal Investigator of the US genetic engineering company Amgen ).
Act
Penninger's discoveries include the isolation of the gene that regulates the internal clock in mice. He showed that osteoporosis is genetically predisposed. Experiments on laboratory mice with the osteoporosis gene removed have shown that their bones are much more robust. In 2010, Penninger and co-workers were able to “ clarify the connection between the consumption of synthetic sex hormones and an increased risk of breast cancer ”.
He has published more than 400 scientific papers in the field of genetics and medicine (as of 2012), some in renowned scientific journals such as Nature or Science .
Awards (selection)
- 2000 - Young leader in medicine in Canada of the Canadian daily newspaper The Globe and Mail
- 2001 - Top 40 under 40 in Canada
- 2003 - Scientist of the Year
- 2004 - Member of the Leopoldina
- 2004 - Austrian of the year
- 2005 - naming of the asteroid (48801) Penninger
- 2006 - Descartes Prize (APOPTOSIS project)
- 2007 - Ernst Jung Prize
- 2007 - Carus Medal
- 2008 - Karl Landsteiner Prize
- 2009 - Member of the Academia Europaea
- 2011 - Fellow of the American Association for the Advancement of Science
- 2012 - Innovator Award of the US Department of Defense (7.4 million US dollars doped)
- 2014 - Wittgenstein Prize
- 2014 - Prize of the City of Vienna for Medical Sciences
Web links
- Short résumé of Josef Penninger
- Extensive résumé of Josef Penninger
- Orf-News: body clock regulator discovered
- Biography, with further honors ( PDF file; 53 kB)
Individual evidence
- ↑ Top researcher Josef Penninger leaves Austria , accessed on February 5, 2018
- ↑ a b Evelyn Devuyst: US Department of Defense invested 7.4 million US dollars in Austrian breast cancer research. Informationsdienst Wissenschaft (idw-online.de), accessed on October 22, 2012 .
- ↑ Member entry of Josef Penninger (with picture) at the German Academy of Natural Scientists Leopoldina , accessed on July 15, 2016.
personal data | |
---|---|
SURNAME | Penninger, Josef |
ALTERNATIVE NAMES | Penninger, Josef Martin (full name) |
BRIEF DESCRIPTION | Austrian physician, scientific director at the Institute for Molecular Biotechnology (IMBA) |
DATE OF BIRTH | 5th September 1964 |
PLACE OF BIRTH | Gurten , Upper Austria |